Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Media-OutReach Newswire Samitivej International Children’s Hospital Expands, Advancing Pediatric Healthcare in Asia-Pacific
Media-OutReach Newswire Special Minds Introduces Singapore's First 1:1 Special Needs Matching Platform
Media-OutReach Newswire Dreamer's Journey 2025" – Empowering Families with Disabilities to Venture Beyond Hong Kong. "Soaring High • Transforming Growth" Hong Kong Press Conference
Media-OutReach Newswire Unleash Your Children's Potential: iCare Eyecare's Solutions Enhance Learning and Sports Engagement